Tutte le notizie su trasylol
An article published on February 21, 2008 in The New England Journal of Medicine provides more evidence of the increased risk of death in patients receiving Trasylol.
leggi »
Sotterra
Patients who received Trasylol had an increased risk of death and kidney failure compared to those who were given aminocapric acid or no drug therapy.
leggi »
Sotterra
Trasylol linked to serious side effects including strokes, heart attacks and kidney failure or renal failure.
leggi »
Sotterra
Bayer suspended sales in November after a big Canadian trial linked the drug to higher death rates, but the company says it still believes Trasylol has a "favorable risk-benefit profile" and consid
leggi »
Sotterra
